uation of 160 treated cases// Cancer. — 1980. — 46. —
p. 2369-72.
15. Berna L., Carrio I., Alonso C. Bone pain palliation with stron-
tium-89 in breast cancer patients with bone metastases and
refractory bone pain// Eur.J.Nucl.Med. — 1995. — 22(10). —
p. 1101-4.
16. Brule G. Co-operative clinical study of 178 patients treated
with «Nolvadex» // The hormonal control of breast cancer. —
Cheshire. — 1978. — p. 35-39.
17. Coleman R.E., Rubens R.D. Clinical course of bone metas-
tases from breast cancer// Brit.J.Cancer. — 1987. — 55. —
p. 61-6.
18. de-Kerk J.M., van-Dijk A., van-het-Schip A.D. Pharmacoki-
netics of rhenium-186 after administration of rhenium-186-
HEDP to patients with bone metastases// J.Nucl.Med. —
1992. — 33(5). — p. 646-51.
19. de-Klerk J.M., van-het-Schip A.D., Zonnenberg B.A. Phase I
study of rhenium-186-HEDP in patients with bone metastases
originating from breast cancer// J.Nnucl.Med. — 1996. —
37(2). — p. 249-52.
20. Deng H., Luo S., Tan T. 153-Sm-EDTMP for moderate and
severe bone cancer pain// — 1995. — 26(4). — p. 391-4.
21. Dokiya T., Yorozu A. Palliative radiotherapy for symptomatic
osseus metastases// Nippon Igaku Hoshasen. — 1995. —
55(9). — p. 677-81.
22. Furr B.J.A., Jordan V.C. The pharmacology and clinical uses
of tamoxifen// Pharmacol. and Ther. — 1984. — 25 (¹2). —
p. 127-205.
23. Galasko C.S. Incidence and distribution of bone metastases//
Clin.Orthop. — 1986. — 210. — p. 14-21.
24. Guerra U.P., Englaro E., Cattruzzi E. Palliative therapy with
rhenium-186-HEDP for bone metastases of breast cancer//
Tumori. — 1997. — 83. — p. 560-62.
25. Hortobagy G.N., Buzdar A.U., Frye D. Oral medroxyproges-
teron acetate in the treatment of metastatic breast cancer//
Breast cancer Res. Treat. — 1985. — 5. — p. 321-26.
26. Hortobagy G.N. Multidisciplinary management of advanced
primary and metastatic breast cancer// Amer.Cancer.Soc.
Nat.Breast.Cancer. — Boston. — Mass. — Aug. — 26-28. —
1993. — Cancer. — 1994. — 1. — p. 416-23.
27. Ingle J.N. Principles of therapy in advanced breast cancer//
Hematol.Oncol.Clin.North Am. — 1989. — 3(4). — p. 743-63.
28. Kave S.B., Woods R.L., Coates A.S. Use of aminoglutethimide
as second-line endocrine therapy in metastatic breast cancer//
Cancer Res. — 1982. — 42. — p. 3445-47.
29. Kawashima M., Maehara Y., Tateno K. The effectiveness of
radiation therapy in bone metastasis from breast cancer// Rin-
sho Hoshasen. — 1989. — 34(4). — p. 501-5.
30. Kokron O. Skelett metastasa sierends. Mammakarzinom in der
Menopause// Ltsch.Z.Oncol. — 1989. — 21. — p. 16.
31. Lee C.K., Aeppli D.M., Unger J. Strontium-89 chloride
(Metastron) for palliative treatment of bone metastases//
Am.J.Clin.Oncol. — 1996. — 19(2). — p. 102-7.
32. Lerner H.J., Band P.R., Israel L. Phase II study of tamoxifen;
report of 74 patients with stage IV breast cancer// Cancer.
Treat.Rep. — 1976. — 60. — p. 1431-35.
33. Morita K., Ito Y. Radiation therapy of osseus metastasis//
Gan.No.Rinsho. — 1988. — 34(9). — p. 1130-8.
34. Îhara K., Yoshida A., Sugahara S. Analisis of patients surviv-
ing for six months after irradiation of bone metastasis//
Gan.No.Rinsho. — 1989. — 35(14). — p. 1655-9.
35. Palmedo H., Bender H., Schomburg A. Pain therapy with rhe-
nium-186 HEDP in multiple bone metastases//
Nuklearmedizin. — 1996. — 35(2). — p. 63-7.
36. Patanaphan V., Salazar O.M., Risco R. Breast cancer:
metastatic patterns and their prognosis// South.Med.J. —
1988. — 81(9). — p. 1109-12.
37. Penn C.R.H. Single dose and fractionated palliative irradia-
tion for osseous metastases// Clin.Radiol. — 1976. — 27. —
p. 405-408.
38. Pizzocaro C., Panarotto M.B., de Agostini A. Experience with
89-strontium treatment of painful osseus metastases from
breast cancer// Tumori. — 1997. — 83. — p. 558-59.
39. Rubens R.D., Fogelman J. Bone metastases// London:
Springer. — 1991.
40. Seki T., Sasamoto H., Yamaji T. Efficacy of etoposide in bone
metastasis of breast cancer// Gan.To.Kagaku.Ruoho. — 1989.
— 16(2). — p. 273-6.
41. Silberstein T.B. The treatment of painful osseous metastases
with phosphorus -32-labeled phosphates// Semin.Oncol. —
1993. — 20 (suppl. 2). — p. 10-21.
42. Smith
I.E.,
Fitzharris
B.M.,
McKinna
J.A.
Aminoglutethimide in treatment of metastatic breast carcino-
ma// Lancet. — 1978. — ii. — p. 646-49.
43. Smith I.E., Harris A.L., Morgan M. Tamoxifen versus
aminoglutethimidi in advanced breast carcinoma: a ran-
domized cross-over trial// Brit.Med.J. — 1981. — 28. —
283. — p. 1432-34.
44. Smith J.R., Macaulay V. Comparison of different encocrine
therapies in management of bone metastases from breast
carcinoma// J.Royal.Soc.Med.Suppl. — 1985. — 9 (v.78).
— p. 15-17.
45. Tong D., Gillick L., Hendrickson F.R. The palliation of
symptomatic osseus metastases// Cancer. — 1982. — 50. —
p. 893-94.
46. Treiberg
R.
Hormon-
und
Chemotherapie
des
Mammakarzinoms// Therapiewoche. — 1989. — 39 (Nll). —
ss.686,688,690,692,694,696,698-699.
47. Uppelschoten G.M., Wanders S.L., de-Jong J.M. Single-dose
radiotherapy (6Gy): palliation in painful bone metastases//
Radiother-Oncol. — 1995. — 36(3). — p. 182-202.
48. Van-Houtte P., Beauvois S., Philippson C. What is the role of
radiotherapy in treatment of breast cancer in 1995?// Rev.
Med.Brux. — 1995. — 16(4). — p. 237-41.
49. Virotta G., Medolago G., Arrigoni S. Rhenium-186-HEDP
for treatment of painful metastases from mammary carcino-
ma// Tumori. — 1997. — 83. — p. 563-65.
50. Wagner W. Radiotherapy of osseus metastases in breast can-
cer// Geburtshilfe-Fauenheilkd. — 1991. — 51(2). — p. 106-8.
51. Werner B., Isacson C., Lundell G. P32-pyrophosphate in
treatment of persistent metastatic bone pain// Acta.Radiolog.
Oncol. — 1980. — 19 (fasc.). — p. 327-29.
Iaeeeaoeaiay iaaeoeia e ?aaaeeeoaoey, 1998, ¹1, n. 5-10.
ÂÎÇÌÎÆÍÎÑÒÈ ÏÀËËÈÀÒÈÂÍÎÃÎ
ËÅ×ÅÍÈß ÐÀÊÀ ÆÅËÓÄÊÀ
A.A. Aaaiia, N.A. ?aii?ia, A.E. Eoiiia
??ineaaneay ainoaa?noaaiiay iaaeoeineay aeaaaiey,
??ineaaeu, ?inney
Iniiaiui ?aaeeaeuiui iaoiaii ea?aiey ?aea ?aeoaea ai
ianoiyuaai a?aiaie yaeyaony oe?o?ae?aneee. Iaiaei aieuoie
a?oiia aieuiuo ?aeii ?aeoaea n ia?ae?ii-?ani?ino?aiaiiui
iiooieaaui i?ioannii e ioaaeaiiuie iaoanoacaie ia ii?ao
auou auiieiaia iia?aoey. N?aaiyy i?iaie?eoaeuiinou ?ecie
i?e ?aea IV noaaee ninoaaeyao 4,6 ianyoa. N iaeeeaoeaiie oa-
eu? o oaeie eaoaai?ee aieuiuo aey ea?aiey eniieuco?ony ?ac-
ee?iua noaiu eae iiii-, oae e iieeoeieioa?aiee. Iaie i?i-
aiaeece?iaaiu ?acoeuoaou ea?aiey 25 aieuiuo. Yoi iaoeaiou n
iaoaaeaiiie ia?ae?iie iiooieu?, eia?uea iaoanoacu a ioaa-
eaiiuo i?aaiao eee i?i?anoa?uea ninaaiea no?oeoo?u. Ea?a-
iea i?iaiaeeinu ii noaia AA? (yoiiicea 120 ia/i
2
a 4-e e 6-e
aie, aa?eaieoei 20 ia/i
2
1-e e 7-e aie, oenieaoei 40 ia/i
2
a 2-
e e 8-e aie). Eioa?aae ia?ao eo?naie — 3 iaaaee. N?aaiee
aic?ano aieuiuo — 54 aiaa. Io??ei auei 18, ?aiuei — 7. Ii
aenoieiae?aneie no?oeoo?a i?aiaeaaaea aaaiiea?oeiiia ?ac-
ee?iie noaiaie ceiea?anoaaiiinoe. Ai oeieioa?aiaaoe?aneiai
ea?aiey o 4 aieuiuo auiieiyeenu iaeeeaoeaiua iia?aoee.
508
Àíòîëîãèÿ íàó÷íûõ ïóáëèêàöèé
